CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2023 Earnings Call Transcript

CollPlant Biotechnologies Ltd. misses on earnings expectations. Reported EPS is $-0.42 EPS, expectations were $-0.07.

Related Keywords

Israel ,Brazil ,Israeli ,Swayampakula Ramakanth ,Collplant Biotechnologie ,Dory Kurowski ,Collplant Holdings Ltd ,Collplant Biotechnologies Ltd ,Allergan ,Israeli Innovation Authority ,Nasdaq ,Biggest Defense Companies In Asia ,Exchange Commission ,Collplant Biotechnologies ,Call Transcript April ,Plant Biotechnologies ,Financial Results ,Fourth Quarter ,Yehiel Tal ,Chief Executive Officer ,Eran Rotem ,Chief Financial Officer ,United Nations Global Compact ,Growing Metro Areas ,Defense Companies ,Collplant Holdings ,